Search for Clinical Trial Results

Sponsored By

Hairy Cell Leukemia - 25 Studies Found

Status Study
Recruiting Study Name: Therapy Optimisation for the Treatment of Hairy Cell Leukemia
Condition: Hairy Cell Leukemia
Date: 2014-04-30
Interventions: Drug: Cladribine s.c. injection, HCL treatment Patients with hairy cell leukemia and the need for treatm
Terminated Study Name: Retreatment Protocol for BL22 Immunotherapy in Relapsed or Refractory Hairy Cell Leukemia
Condition: Hairy Cell Leukemia
Date: 2009-06-17
Interventions: Drug: BL22 (CAT-3888) 30 micrograms/kg intravenous over 30 minutes every other day (QOD) on days 1, 3, 5
Active, not recruiting Study Name: LMB-2 to Treat Hairy Cell Leukemia
Condition: Hairy Cell Leukemia
Date: 2006-05-03
Interventions: Drug: Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin LMB-2 Infusion: 40 micro-g/Kg will be infused in 50 ml of 0.
Recruiting Study Name: Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia
Condition: Hairy Cell Leukemia
Date: 2009-06-17
Interventions:
  • Drug: Cladribine Cladribine 0.
Completed Study Name: Rituximab in Hairy Cell Leukemia: a Multicenter Retrospective Study
Condition: Hairy-cell Leukemia
Date: 2016-08-25
Interventions: Other: Data collection
Recruiting Study Name: Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia
Condition: Hairy Cell Leukemia
Date: 2010-01-29
Interventions:
  • Drug: Pentostatin 28 patients

Completed Study Name: A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia
Condition: Hairy Cell Leukemia
Date: 1999-11-03
Interventions: Drug: Roferon-A
Active, not recruiting Study Name: BRAF Inhibitor, Vemurafenib, in Patients With Relapsed or Refractory Hairy Cell Leukemia
Condition: Hairy Cell Leukemia
Date: 2012-10-17
Interventions: Drug: Vemurafenib Patients will receive vemurafenib at a dose of 960mg orally b.i.d. continuously in cyc
Recruiting Study Name: Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia
Condition:
  • Hairy Cell Leukemia
  • Hairy Cell Leukemia Date: 2013-04-24
    Interventions:
    • Drug: Ibrutinib Given PO
Completed Study Name: Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia With Cladribine Plus Rituximab
Condition: Hairy Cell Leukemia (HCL)
Date: 2014-05-21
Interventions: Drug: 2CdA +/- Rituximab Cladribine 0.14 mg/kg daily subcutaneous bolus injection Rituximab 375 mg/m
Next >>>